- Home
- Publications
- Publication Search
- Publication Details
Title
Gene Therapies for Primary Immune Deficiencies
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-25
DOI
10.3389/fimmu.2021.648951
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early Outcome of a Phase I/II Clinical Trial (NCT03538899) of Gene-Corrected Autologous CD34+ Hematopoietic Cells and Low-Exposure Busulfan in Newly Diagnosed Patients with Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID)
- (2020) Morton J. Cowan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Lentiviral gene therapy for X-linked chronic granulomatous disease
- (2020) Donald B. Kohn et al. NATURE MEDICINE
- Excellent Outcomes Following Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: A PIDTC Report
- (2020) Lauri Burroughs et al. BLOOD
- Haematopoietic Cell Transplantation in Chronic Granulomatous Disease: a Study on 712 Children and Adults
- (2020) Robert Chiesa et al. BLOOD
- Gene therapy for Wiskott-Aldrich syndrome: History, new vectors, future directions
- (2020) Francesca Ferrua et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Hematopoietic Tumors in a Mouse Model of X-linked Chronic Granulomatous Disease after Lentiviral Vector-Mediated Gene Therapy
- (2020) Raisa Jofra Hernández et al. MOLECULAR THERAPY
- Gene therapy using haematopoietic stem and progenitor cells
- (2020) Giuliana Ferrari et al. NATURE REVIEWS GENETICS
- Anti-human CD117 antibody-mediated bone marrow niche clearance in non-human primates and humanized NSG mice
- (2019) Hye-Sook Kwon et al. BLOOD
- Lentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX Syndrome
- (2019) Katelyn E. Masiuk et al. Cell Stem Cell
- Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges
- (2019) Marina Cavazzana et al. NATURE REVIEWS DRUG DISCOVERY
- Lentiviral gene therapy corrects platelet phenotype and function in Wiskott-Aldrich patients
- (2019) Lucia Sereni et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1
- (2019) Ewelina Mamcarz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
- (2019) Francesca Ferrua et al. Lancet Haematology
- Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT
- (2019) Rebecca A. Marsh et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Mouse models in hematopoietic stem cell gene therapy and genome editing
- (2019) Stefan Radtke et al. BIOCHEMICAL PHARMACOLOGY
- Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome
- (2019) Roxane Labrosse et al. BLOOD
- Gene therapy for severe combined immunodeficiencies and beyond
- (2019) Alain Fischer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability
- (2018) Beatriz E. Marciano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- 2018 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference
- (2018) JOURNAL OF CLINICAL IMMUNOLOGY
- Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety
- (2018) Maria Pia Cicalese et al. MOLECULAR THERAPY
- Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
- (2018) Alexis A. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
- (2018) Caroline Y. Kuo et al. Cell Reports
- Leukocyte adhesion deficiency-I: A comprehensive review of all published cases
- (2018) Elena Almarza Novoa et al. Journal of Allergy and Clinical Immunology-In Practice
- Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
- (2018) Valentina Poletti et al. Molecular Therapy-Methods & Clinical Development
- Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency
- (2018) Donald B. Kohn et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Genetic Landscape of SCID in the US and Canada in the Current Era (2010-2018)
- (2018) Christopher C. Dvorak et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Newborn Screening for Severe Combined Immunodeficiency in the United States
- (2018) Morna J. Dorsey et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations
- (2017) Kathryn L. Bradford et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency
- (2017) Kit L. Shaw et al. JOURNAL OF CLINICAL INVESTIGATION
- Interleukin-12 and Interleukin-23 Blockade in Leukocyte Adhesion Deficiency Type 1
- (2017) Niki M. Moutsopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency
- (2016) Maria Pia Cicalese et al. BLOOD
- Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions
- (2016) Maren Weisser et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin
- (2016) Rahul Palchaudhuri et al. NATURE BIOTECHNOLOGY
- Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency
- (2016) Suk See De Ravin et al. Science Translational Medicine
- Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing
- (2015) Ulrich Siler et al. CURRENT GENE THERAPY
- Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome
- (2015) Salima Hacein-Bey Abina et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Successful RAG1-SCID gene therapy depends on the level of RAG1 expression
- (2014) Karin Pike-Overzet et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
- (2014) Salima Hacein-Bey-Abina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Therapy for Wiskott-Aldrich Syndrome--Long-Term Efficacy and Genotoxicity
- (2014) C. J. Braun et al. Science Translational Medicine
- SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID
- (2013) C. Schuetz et al. BLOOD
- Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study
- (2013) Tayfun Güngör et al. LANCET
- Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
- (2013) A. Aiuti et al. SCIENCE
- Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency
- (2012) A. Hassan et al. BLOOD
- Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
- (2012) F. Candotti et al. BLOOD
- Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study
- (2011) D. Moratto et al. BLOOD
- Gene therapy for the Wiskott–Aldrich syndrome
- (2011) Anne Galy et al. Current Opinion in Allergy and Clinical Immunology
- Gain-of-function mutations ininterleukin-7 receptor-α(IL7R) in childhood acute lymphoblastic leukemias
- (2011) Chen Shochat et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Retroviral Gene Therapy for X-linked Chronic Granulomatous Disease: Results From Phase I/II Trial
- (2011) Hyoung Jin Kang et al. MOLECULAR THERAPY
- Long-Term Persistence of a Polyclonal T Cell Repertoire After Gene Therapy for X-Linked Severe Combined Immunodeficiency
- (2011) H. B. Gaspar et al. Science Translational Medicine
- A Tale of Two SCIDs
- (2011) K. L. Shaw et al. Science Translational Medicine
- Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction
- (2011) H. B. Gaspar et al. Science Translational Medicine
- Clinical spectrum, pathophysiology and treatment of the Wiskott–Aldrich syndrome
- (2010) Michael H Albert et al. CURRENT OPINION IN HEMATOLOGY
- Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: Advances in Biology and Future Directions for Treatment
- (2010) Sung-Yun Pai et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Biochemical Correction of X-CGD by a Novel Chimeric Promoter Regulating High Levels of Transgene Expression in Myeloid Cells
- (2010) Giorgia Santilli et al. MOLECULAR THERAPY
- Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
- (2010) Stefan Stein et al. NATURE MEDICINE
- Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
- (2010) Salima Hacein-Bey-Abina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stem-Cell Gene Therapy for the Wiskott–Aldrich Syndrome
- (2010) Kaan Boztug et al. NEW ENGLAND JOURNAL OF MEDICINE
- Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils
- (2009) E. M. Kang et al. BLOOD
- Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection
- (2009) R. E. Throm et al. BLOOD
- Wiskott-Aldrich syndrome
- (2009) Luigi D Notarangelo et al. CURRENT OPINION IN HEMATOLOGY
- Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures
- (2009) Sven Ansorge et al. JOURNAL OF GENE MEDICINE
- Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
- (2009) Alessandro Aiuti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
- (2008) Steven J. Howe et al. JOURNAL OF CLINICAL INVESTIGATION
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search